Dafne Franz Demane
Overview
Explore the profile of Dafne Franz Demane including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
220
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yofe I, Landsberger T, Yalin A, Solomon I, Costoya C, Demane D, et al.
Nat Cancer
. 2022 Nov;
3(11):1404.
PMID: 36376510
No abstract available.
2.
Yofe I, Landsberger T, Yalin A, Solomon I, Costoya C, Demane D, et al.
Nat Cancer
. 2022 Oct;
3(11):1336-1350.
PMID: 36302895
Despite the clinical success of checkpoint inhibitors, a substantial gap still exists in our understanding of their mechanism of action. While antibodies to cytotoxic T lymphocyte-associated protein-4 (CTLA-4) were developed...
3.
Solomon I, Amann M, Goubier A, Vargas F, Zervas D, Qing C, et al.
Nat Cancer
. 2021 Mar;
1(12):1153-1166.
PMID: 33644766
Intratumoral regulatory T cell (Treg) abundance associates with diminished anti-tumor immunity and poor prognosis in human cancers. Recent work demonstrates that CD25, the high affinity receptor subunit for IL-2, is...
4.
Sledzinska A, Vila de Mucha M, Bergerhoff K, Hotblack A, Demane D, Ghorani E, et al.
Immunity
. 2020 Jan;
52(1):151-166.e6.
PMID: 31924474
In addition to helper and regulatory potential, CD4 T cells also acquire cytotoxic activity marked by granzyme B (GzmB) expression and the ability to promote rejection of established tumors. Here,...